~~<i id='85E22FC604'><strike id='85E22FC604'><tt id='85E22FC604'><pre id='85E22FC604'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：entertainment 2025-09-30 09:08:54 Page View：81

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA panel to weigh safety of artificial wombs for preterm births
Next article： FDA approval of Sarepta Duchenne genetic therapy gives me hope

explore

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Redefining sustainability for the pharmaceutical industry

BoxesofsyringesdonatedtotheCovid-19vaccinationcampaigninCuba,beingunloadedinHavana.PhotobyYAMILLAGE/

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Assistant physicians can help address the primary care shortage

AdobeArecentstudybytheAssociationofAmericanMedicalCollegesprojects ashortageofbetween17,800and48,000